vimarsana.com

Latest Breaking News On - Sanofi chief executive paul - Page 1 : vimarsana.com

France s Sanofi Partners With OpenAI to Accelerate Drug Development

By Mauro Orru French pharmaceutical company Sanofi is partnering with Sam Altman s OpenAI and AI pharma company Formation Bio to expedite the development of new medicines, tapping artificial.

LONDON BRIEFING: BP promises buybacks and 4% annual dividend hikes

LONDON BRIEFING: BP promises buybacks and 4% annual dividend hikes Tue, 3rd Aug 2021 08:12 (Alliance News) - BP on Tuesday lifted its quarterly dividend and unveiled a USD1.4 billion share buyback, while dangling the prospect of more of both to shareholders. The oil major swung to an underlying replacement cost profit for the second quarter of USD2.80 billion from a USD6.68 billion loss a year ago. It also marked an improvement from the first quarter of 2021, when it recorded profit of USD2.63 billion. Profit was driven by higher oil prices and margins, offset by a lower result in gas marketing and trading

Sanofi to buy U S mRNA partner Translate Bio in $3 2 billion deal

Sanofi to buy U.S. mRNA partner Translate Bio in $3.2 billion deal By Matthias Blamont Reuters PARIS (Reuters) -Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters exclusive report. Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion for Translate Bio. The boards of both companies have approved the deal, and the chief executive of Translate Bio and the U.S. company s largest shareholder have backed the takeover offer, Sanofi and Translate Bio said in a joint statement.

Sanofi to buy U S mRNA partner Translate Bio in $3 2 bln deal

Article content PARIS Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters exclusive report. Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion for Translate Bio. We apologize, but this video has failed to load. Try refreshing your browser, or Sanofi to buy U.S. mRNA partner Translate Bio in $3.2 bln deal Back to video The boards of both companies have approved the deal, and the chief executive of Translate Bio and the U.S. company’s largest shareholder have backed the takeover offer, Sanofi and Translate Bio said in a joint statement.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.